Overview

Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.
Phase:
N/A
Details
Lead Sponsor:
Cairo University
Treatments:
Hydroxyethyl Starch Derivatives